Form 8-K - Current report:
SEC Accession No. 0001447028-24-000066
Filing Date
2024-08-05
Accepted
2024-08-05 16:13:03
Documents
13
Period of Report
2024-08-05
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K abus-20240805.htm   iXBRL 8-K 30224
  Complete submission text file 0001447028-24-000066.txt   154077

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20240805.xsd EX-101.SCH 1898
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20240805_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20240805_pre.xml EX-101.PRE 12506
16 EXTRACTED XBRL INSTANCE DOCUMENT abus-20240805_htm.xml XML 3124
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 241174891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)